{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T03:51:43Z","timestamp":1771300303303,"version":"3.50.1"},"reference-count":34,"publisher":"Hindawi Limited","issue":"4","license":[{"start":{"date-parts":[[2011,11,12]],"date-time":"2011-11-12T00:00:00Z","timestamp":1321056000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2011,11,12]],"date-time":"2011-11-12T00:00:00Z","timestamp":1321056000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1111\/j.1600-0404.2011.01607.x","type":"journal-article","created":{"date-parts":[[2011,11,12]],"date-time":"2011-11-12T08:35:39Z","timestamp":1321086939000},"page":"234-240","source":"Crossref","is-referenced-by-count":19,"title":["Cancer risk in people with epilepsy using valproate-sodium"],"prefix":"10.1155","volume":"125","author":[{"given":"G.","family":"Singh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. S.","family":"Bell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. Hern\u00e1iz","family":"Driever","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. W.","family":"Sander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"98","published-online":{"date-parts":[[2011,11,12]]},"reference":[{"key":"10.1111\/j.1600-0404.2011.01607.x-BIB1|cit1","unstructured":"Statistics on the risk of developing cancer http:\/\/info.cancerresearchuk.org\/prod_consump"},{"key":"10.1111\/j.1600-0404.2011.01607.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0140-6736(74)92906-7","article-title":"Are anticonvulsants oncogenic?","volume":"1","author":"Clemmesen","year":"1974","journal-title":"Lancet"},{"key":"10.1111\/j.1600-0404.2011.01607.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/brain\/awh363","article-title":"Cancer risk in people with epilepsy: the role of antiepileptic drugs","volume":"128","author":"Singh","year":"2005","journal-title":"Brain"},{"key":"10.1111\/j.1600-0404.2011.01607.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1136\/jnnp.2005.083931","article-title":"Epilepsy as a risk factor for cancer","volume":"77","author":"Adelow","year":"2006","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1111\/j.1600-0404.2011.01607.x-BIB5|cit5","first-page":"131","article-title":"Dose-response relationship for phenobarbitone promotion of liver tumours initiated by single dose dimethylnitrosamine","volume":"67","author":"Driver","year":"1986","journal-title":"Br J Exp Pathol"},{"key":"10.1111\/j.1600-0404.2011.01607.x-BIB6|cit6","first-page":"1506","article-title":"Reduction and enhancement by phenobarbital of hepatocarcinogenesis induced in the rat by 2-acetylaminofluorene","volume":"31","author":"Peraino","year":"1971","journal-title":"Cancer Res"},{"key":"10.1111\/j.1600-0404.2011.01607.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1080\/10915810151115191","article-title":"Enhancement of N-nitrosodiethylamine-initiated hepatocarcinogenesis by phentoin in male F344\/NCr rats at a dose causing maximal induction of CYP2B","volume":"20","author":"Diwan","year":"2001","journal-title":"Int J Toxicol"},{"key":"10.1111\/j.1600-0404.2011.01607.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/0147-6513(78)90014-3","article-title":"Is phenobarbital carcinogenic? A follow-up of 8078 epileptics","volume":"1","author":"Clemmesen","year":"1978","journal-title":"Ecotoxicol Environ Saf"},{"key":"10.1111\/j.1600-0404.2011.01607.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1093\/jnci\/81.10.803","article-title":"Cancer among epileptic patients exposed to anticonvulsant drugs","volume":"81","author":"Olsen","year":"1989","journal-title":"J Natl Cancer Inst"},{"key":"10.1111\/j.1600-0404.2011.01607.x-BIB10|cit10","first-page":"294","article-title":"Antiepileptic treatment and risk for hepatobiliary cancer and malignant lymphoma","volume":"55","author":"Olsen","year":"1995","journal-title":"Cancer Res"},{"key":"10.1111\/j.1600-0404.2011.01607.x-BIB11|cit11","first-page":"83","article-title":"Cancer incidence in a cohort of patients with seizure disorders","volume":"77","author":"Shirts","year":"1986","journal-title":"J Natl Cancer Inst"},{"key":"10.1111\/j.1600-0404.2011.01607.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/S0140-6736(79)91505-8","article-title":"Anticonvulsant drugs and cancer. A cohort study in patients with severe epilepsy","volume":"2","author":"White","year":"1979","journal-title":"Lancet"},{"key":"10.1111\/j.1600-0404.2011.01607.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.eplepsyres.2008.11.001","article-title":"Cancer mortality amongst people with epilepsy: a study of two cohorts with severe and presumed milder epilepsy","volume":"83","author":"Singh","year":"2009","journal-title":"Epilepsy Res"},{"key":"10.1111\/j.1600-0404.2011.01607.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/med.20027","article-title":"Evolving anticancer drug valproic acid: insights into the mechanism and clinical studies","volume":"25","author":"Blaheta","year":"2005","journal-title":"Med Res Rev"},{"key":"10.1111\/j.1600-0404.2011.01607.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"6969","DOI":"10.1093\/emboj\/20.24.6969","article-title":"Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells","volume":"20","author":"Gottlicher","year":"2001","journal-title":"EMBO J"},{"key":"10.1111\/j.1600-0404.2011.01607.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1365-2141.2008.07426.x","article-title":"Valproate synergizes with purine nucleoside analogues to induce apoptosis of B-chronic lymphocytic leukaemia cells","volume":"144","author":"Bouzar","year":"2009","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1600-0404.2011.01607.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"8903","DOI":"10.1158\/0008-5472.CAN-05-2726","article-title":"Sequential valproic acid\/all-trans retinoic acid treatment reprograms differentiation in refractory and high-risk acute myeloid leukemia","volume":"66","author":"Cimino","year":"2006","journal-title":"Cancer Res"},{"key":"10.1111\/j.1600-0404.2011.01607.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1093\/qjmed\/91.6.445","article-title":"The General Practice Research Database. Scientific and Ethical Advisory Group","volume":"91","author":"Lawson","year":"1998","journal-title":"QJM"},{"key":"10.1111\/j.1600-0404.2011.01607.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1158\/1055-9965.EPI-08-0646","article-title":"Cancer risk in long-term users of valproate: a population-based case-control study","volume":"18","author":"Hallas","year":"2009","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1111\/j.1600-0404.2011.01607.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1093\/annonc\/mdl498","article-title":"Estimates of the cancer incidence and mortality in Europe in 2006","volume":"18","author":"Ferlay","year":"2007","journal-title":"Ann Oncol"},{"key":"10.1111\/j.1600-0404.2011.01607.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1136\/jnnp.2003.029223","article-title":"Reducing mortality: an important aim of epilepsy management","volume":"75","author":"Sander","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1111\/j.1600-0404.2011.01607.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1002\/ana.70","article-title":"Mortality in epilepsy in the first 11 to 14\u2003years after diagnosis: multivariate analysis of a long-term, prospective, population-based cohort","volume":"49","author":"Lhatoo","year":"2001","journal-title":"Ann Neurol"},{"issue":"Suppl. 11","key":"10.1111\/j.1600-0404.2011.01607.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1528-1167.2005.00406.x","article-title":"Cause-specific mortality in epilepsy","volume":"46","author":"Lhatoo","year":"2005","journal-title":"Epilepsia"},{"key":"10.1111\/j.1600-0404.2011.01607.x-BIB24|cit24","first-page":"97","article-title":"Induction of differentiation and suppression of malignant phenotype of human neuroblastoma BE(2)-C cells by valproic acid: enhancement by combination with interferon-alpha","volume":"20","author":"Cinatl","year":"2002","journal-title":"Int J Oncol"},{"key":"10.1111\/j.1600-0404.2011.01607.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1210\/jc.2004-1355","article-title":"Valproic acid induces apoptosis and cell cycle arrest in poorly differentiated thyroid cancer cells","volume":"90","author":"Catalano","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1600-0404.2011.01607.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ejphar.2007.01.022","article-title":"Human melatonin MT1 receptor induction by valproic acid and its effects in combination with melatonin on MCF-7 breast cancer cell proliferation","volume":"560","author":"Jawed","year":"2007","journal-title":"Eur J Pharmacol"},{"key":"10.1111\/j.1600-0404.2011.01607.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S0145-2126(01)00151-5","article-title":"Valproic acid induces apoptosis in human leukemia cells by stimulating both caspase-dependent and -independent apoptotic signaling pathways","volume":"26","author":"Kawagoe","year":"2002","journal-title":"Leuk Res"},{"key":"10.1111\/j.1600-0404.2011.01607.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1179\/joc.2006.18.4.415","article-title":"Synergistic effects of valproic acid and mitomycin C in adenocarcinoma cell lines and fresh tumor cells of patients with colon cancer","volume":"18","author":"Friedmann","year":"2006","journal-title":"J Chemother"},{"key":"10.1111\/j.1600-0404.2011.01607.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1097-4652(200007)184:1<1::AID-JCP1>3.0.CO;2-7","article-title":"Histone deacetylases, transcriptional control, and cancer","volume":"184","author":"Cress","year":"2000","journal-title":"J Cell Physiol"},{"key":"10.1111\/j.1600-0404.2011.01607.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1111\/j.1528-1167.2009.02131.x","article-title":"Effects of levetiracetam and valproate on reproductive endocrine function studied in human ovarian follicular cells","volume":"50","author":"Tauboll","year":"2009","journal-title":"Epilepsia"},{"key":"10.1111\/j.1600-0404.2011.01607.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/j.febslet.2007.02.045","article-title":"Histone deacetylase inhibitors suppress natural killer cell cytolytic activity","volume":"581","author":"Ogbomo","year":"2007","journal-title":"FEBS Lett"},{"key":"10.1111\/j.1600-0404.2011.01607.x-BIB32|cit32","first-page":"633","article-title":"The histone deacetylase inhibitors suberoylanilide hydroxamic (Vorinostat) and valproic acid induce irreversible and MDR1-independent resistance in human colon cancer cells","volume":"31","author":"Fedier","year":"2007","journal-title":"Int J Oncol"},{"key":"10.1111\/j.1600-0404.2011.01607.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/CAD.0b013e3283262a32","article-title":"Acquired vorinostat resistance shows partial cross-resistance to \u2018second-generation\u2019 HDAC inhibitors and correlates with loss of histone acetylation and apoptosis but not with altered HDAC and HAT activities","volume":"20","author":"Dedes","year":"2009","journal-title":"Anticancer Drugs"},{"key":"10.1111\/j.1600-0404.2011.01607.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s00228-002-0429-6","article-title":"Cancer incidence among patients using antiepileptic drugs: a long-term follow-up of 28,000 patients","volume":"58","author":"Lamminpaa","year":"2002","journal-title":"Eur J Clin Pharmacol"}],"container-title":["Acta Neurologica Scandinavica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0404.2011.01607.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0404.2011.01607.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1600-0404.2011.01607.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T12:49:59Z","timestamp":1671540599000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0404.2011.01607.x"}},"subtitle":["<b>Cancer risk associated with valproate use<\/b>"],"short-title":[],"issued":{"date-parts":[[2011,11,12]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,4]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1600-0404.2011.01607.x","archive":["Portico"],"relation":{},"ISSN":["0001-6314"],"issn-type":[{"value":"0001-6314","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11,12]]}}}